Infectious complications following T-cell depleted hematopoietic stem-cell transplantation

Cytotherapy

Volumn 3, Issue 3, 2001, Pages 165-173

  Novitzky, N ^a   Rouskova, A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Antibiotics; Opportunistic infections; Sepsis; T cell depletion

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; AMINOGLYCOSIDE; AMPHOTERICIN; AMPHOTERICIN DEOXYCHOLIC ACID; ANTIBIOTIC AGENT; BUSULFAN; CAMPATH 1 IMMUNOGLOBULIN G; CEPHALOSPORIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; IMMUNOGLOBULIN; OFLOXACIN; PENTAMIDINE; SULFONAMIDE; THIOTEPA; UNCLASSIFIED DRUG; CAMPATH 1G; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BLOOD DISEASE; BLOOD TRANSFUSION; BONE MARROW DEPRESSION; CANCER RECURRENCE; CATHETER INFECTION; CHILD; DISEASE DURATION; DISEASE SEVERITY; FATALITY; FEMALE; FEVER; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; GRAM POSITIVE BACTERIUM; HEMATOLOGICAL PARAMETERS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HOSPITALIZATION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INDWELLING CATHETER; INFECTIOUS COMPLICATION; INTRAVENOUS CATHETER; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MICROBIOLOGICAL EXAMINATION; MORBIDITY; NEUTROPENIA; NONHUMAN; OPPORTUNISTIC INFECTION; PERIPHERAL BLOOD STEM CELL; PREVALENCE; PYREXIA IDIOPATHICA; RETROSPECTIVE STUDY; SEPSIS; SURVIVAL; T LYMPHOCYTE; VIRUS INFECTION; WHOLE BODY RADIATION; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CONVALESCENCE; DRUG EFFECT; HEMATOPOIESIS; IATROGENIC DISEASE; IMMUNOLOGY; INFECTION; METHODOLOGY; MYCOSIS; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RECURRENT DISEASE; SURVIVAL RATE; TREATMENT FAILURE;

ADOLESCENT; ADULT; ANTIBIOTICS; ANTIBODIES, MONOCLONAL; BACTERIAL INFECTIONS; BONE MARROW TRANSPLANTATION; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIESIS; HUMAN; IMMUNOSUPPRESSION; INFECTION; MALE; MIDDLE AGE; MYCOSES; OPPORTUNISTIC INFECTIONS; RECOVERY OF FUNCTION; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; T-LYMPHOCYTES; TREATMENT FAILURE; VIRUS DISEASES;

EID: 0034754677     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/146532401753173990     Document Type: Article

References (19)

1. Bone-marrow transplantation
2. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells
3. Empiric antimicrobials therapy or febrile granulocytopenic cancer patients: Lessons from four EORTC trials
4. A modified right atrial catheter for access to the venous system in marrow transplant recipients
5. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciproafloxacin alone on the development of acute graft vs host disease after marrow transplantation in patients with haematologic malignancies, final results and long-term follow up on an open label prospective randomised trial
6. Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT
7. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology and outcome of bacteriemia and fungemia in adults
8. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer
9. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with gancyclovir
10. Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: Graft-versus-host disease and graft-versus-leukemia effect
11. Collection and cryopreservation of human stem and progenitor cells for bone marrow transplantation
12. Increased risk of infection in marrow transplant patients receiving methyl-prednisolone for graft vs host disease prevention
13. Bone marrow transplantation depleted of T cells followed by repletion with incremental doses of donor lymphocytes for relapsing patients with chronic myeloid leukemia: A therapeutic strategy
14. Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells
15. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies
16. Central venous catheter-leated complications after bone marrow transplantation in children with haematological malignancies
17. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: A randomized trial
18. Life-threatening infections occurring more than three months after bone marrow transplantation
19. Fulminant hepatitis B following bone marrow transplantation in an HbsAg-negative HbsAb-positive recipient; Reactivation of dormant virus during the immunosuppressive period